CARDIOVASCULAR DISEASES AMONG YOUNG PEOPLE: AETIOLOGICAL DETERMINANTS, CONTEMPORARY TREATMENT STRATEGIES AND PREVENTIVE INTERVENTIONS

Authors

Keywords:

cardiovascular disease; young adults; premature atherosclerosis; risk factors; primary prevention; familial hypercholesterolaemia; lifetime risk.

Abstract

Cardiovascular disease (CVD) is conventionally regarded as a disorder of middle and old age, yet the decline in cardiovascular mortality achieved in older populations has not been matched among adolescents and young adults, and rising rates of obesity, hypertension, physical inactivity and substance use in early life threaten to reverse several decades of progress. This review synthesises current evidence on the causes of CVD in young people, the treatment strategies available to them and the preventive measures most likely to reduce their lifetime risk. A structured narrative review was conducted: landmark autopsy studies, prospective cohorts, registries of premature myocardial infarction, randomised trials, pooled global analyses and international guidelines published between 1998 and 2023 were purposively selected and synthesised thematically under four domains – burden, aetiology, treatment and prevention. Atherosclerosis begins in adolescence, and its extent is proportional to the number of conventional risk factors present. Childhood risk factor levels predict fatal cardiovascular events in adulthood, and blood pressure or LDL cholesterol elevations before the age of 40 confer excess risk independent of later exposure. Globally, 81% of school-going adolescents are insufficiently active, and the number of children and adolescents with obesity rose from 11 million in 1975 to 124 million in 2016. In registries of premature myocardial infarction, most patients carried at least one modifiable risk factor, but only a minority would have qualified for preventive pharmacotherapy beforehand, whereas early statin therapy in familial hypercholesterolaemia markedly reduced events by the age of 39. Cardiovascular disease in the young is therefore largely driven by modifiable, early-acquired exposures that current short-term risk models fail to capture; a life-course approach combining population-level policy, systematic screening for inherited and early-onset risk factors and timely treatment is warranted, and region-specific data, particularly from Central Asia, remain a research priority.

References

1. World Health Organization. (2021). Cardiovascular diseases (CVDs): Fact sheet. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. Roth, G. A., Mensah, G. A., Johnson, C. O., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982–3021.

3. Andersson, C., & Vasan, R. S. (2018). Epidemiology of cardiovascular disease in young individuals. Nature Reviews Cardiology, 15(4), 230–240.

4. Arora, S., Stouffer, G. A., Kucharska-Newton, A. M., et al. (2019). Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction: The ARIC Community Surveillance Study. Circulation, 139(8), 1047–1056.

5. Gupta, A., Wang, Y., Spertus, J. A., et al. (2014). Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. Journal of the American College of Cardiology, 64(4), 337–345.

6. Collet, J.-P., Zeitouni, M., Procopi, N., et al. (2019). Long-term evolution of premature coronary artery disease. Journal of the American College of Cardiology, 74(15), 1868–1878.

7. Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. New England Journal of Medicine, 338(23), 1650–1656.

8. Strong, J. P., Malcom, G. T., McMahan, C. A., et al. (1999). Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA, 281(8), 727–735.

9. Juonala, M., Magnussen, C. G., Berenson, G. S., et al. (2011). Childhood adiposity, adult adiposity, and cardiovascular risk factors. New England Journal of Medicine, 365(20), 1876–1885.

10. Jacobs, D. R., Woo, J. G., Sinaiko, A. R., et al. (2022). Childhood cardiovascular risk factors and adult cardiovascular events. New England Journal of Medicine, 386(20), 1877–1888.

11. Domanski, M. J., Tian, X., Wu, C. O., et al. (2020). Time course of LDL cholesterol exposure and cardiovascular disease event risk. Journal of the American College of Cardiology, 76(13), 1507–1516.

12. Zhang, Y., Vittinghoff, E., Pletcher, M. J., et al. (2019). Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events. Journal of the American College of Cardiology, 74(3), 330–341.

13. Yusuf, S., Hawken, S., Ôunpuu, S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet, 364(9438), 937–952.

14. Singh, A., Collins, B. L., Gupta, A., et al. (2018). Cardiovascular risk and statin eligibility of young adults after an MI: Partners YOUNG-MI Registry. Journal of the American College of Cardiology, 71(3), 292–302.

15. Baethge, C., Goßner-Wiltsche, S., & Mertens, S. (2019). SANRA—a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, 4, 5.

16. Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.

17. Yano, Y., Reis, J. P., Colangelo, L. A., et al. (2018). Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with cardiovascular events later in life. JAMA, 320(17), 1774–1782.

18. NCD Risk Factor Collaboration. (2017). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet, 390(10113), 2627–2642.

19. Guthold, R., Stevens, G. A., Riley, L. M., & Bull, F. C. (2020). Global trends in insufficient physical activity among adolescents: A pooled analysis of 298 population-based surveys with 1.6 million participants. The Lancet Child & Adolescent Health, 4(1), 23–35.

20. Song, P., Zhang, Y., Yu, J., et al. (2019). Global prevalence of hypertension in children: A systematic review and meta-analysis. JAMA Pediatrics, 173(12), 1154–1163.

21. Visseren, F. L. J., Mach, F., Smulders, Y. M., et al. (2021). 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal, 42(34), 3227–3337.

22. Stone, N. J., Smith, S. C., Orringer, C. E., et al. (2022). Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review. Journal of the American College of Cardiology, 79(8), 819–836.

23. Luirink, I. K., Wiegman, A., Kusters, D. M., et al. (2019). 20-year follow-up of statins in children with familial hypercholesterolemia. New England Journal of Medicine, 381(16), 1547–1556.

24. Arnett, D. K., Blumenthal, R. S., Albert, M. A., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation, 140(11), e596–e646.

25. Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., et al. (2017). Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics, 140(3), e20171904.

26. Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A. M., et al. (2022). Life's Essential 8: Updating and enhancing the American Heart Association's construct of cardiovascular health. Circulation, 146(5), e18–e43.

27. Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., et al. (2006). Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation, 113(6), 791–798.

28. Berry, J. D., Dyer, A., Cai, X., et al. (2012). Lifetime risks of cardiovascular disease. New England Journal of Medicine, 366(4), 321–329.

29. Estruch, R., Ros, E., Salas-Salvadó, J., et al. (2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378(25), e34.

Published

2026-10-16